Skip to main content

Hand-Foot Syndrome

Hand-foot syndrome


Hand-foot syndrome (HFS), also called palmarplantar erythrodysesthesia syndrome (PPES), is a relatively common side effect associated with high dosage chemotherapy treatments involving fluorouracil (5-FU) and drugs belonging to the chemical class called anthracyclines.

Anthracyclines have been widely used since the 1960s as dose-limited chemotherapy drugs for a variety of cancers, particularly leukemia, metastatic breast cancer , ovarian cancer , and colorectal cancer. The most familiar anthracyclines are capecitabine (Xeloda), daunorubicin (Cerubidine), doxorubicin (Adriamycin), idarubicin (Idamycin), and vinorelbine (Navelbine). Each of these drugs is broken down into 5-FU by chemicals inside the cancer cells.

A dose-limited drug is a drug for which the maximum dose is determined by the reactions of an individual patient. Symptoms of HFS usually indicate that a patient is receiving too much 5-FU or a particular anthracycline. In such a case, the dosage of the drug that is causing HFS is usually decreased until these symptoms either disappear completely or become tolerable to the patient.

The primary symptom of HFS is a tingling sensation and/or numbness of the skin, particularly on the palms of the hands or the soles of the feet. Swelling and redness (erythema) often accompany this symptom. In severe cases, the skin may peel, develop ulcerations or blisters, and cause severe pain. In the most extreme cases, symptoms of HFS may make it difficult, or impossible, for the patient to grasp small objects, walk, or conduct other normal daily activities.


The symptoms of HFS are believed to be caused by some of the chemicals that 5-FU is broken down into by the natural biochemical processes of the body. Since all anthracycline drugs chemically breakdown into 5-FU, these drugs will all eventually be broken down into the chemicals that can cause the symptoms of HFS. For reasons that are not clear, some patients seem more prone to developing symptoms of HFS than other patients.


The symptoms of HFS are usually alleviated by lowering the dosage of the drug that the patient is receiving. In severe cases of HFS, it may be necessary to discontinue the use of the drug that is causing these symptoms. In some, but not all, patients the symptoms of HFS are reduced by treatment with steroid-containing skin creams, such as hydrocortisone.

Alternative and complementary therapies

Treatment of the hands and feet with an aloe veracontaining skin cream may help to alleviate some of the symptoms of HFS. Topical treatment of the skin with dimethyl sulfoxide (DMSO) has also been suggested as an alternative treatment.



"Capecitabine gives new life to fluorouracil in treatment of breast cancer." Drugs and Therapy Perspectives 16 (26 September 2000): 1-5.

"Daunorubicin liposomal: First report of palmar-plantar erythrodysesthesia syndrome." Reactions (25 November 2000): 829.

Hui, Yuk Fung and Jorge E. Cortes. "Palmar-Plantar Erythrodysesthesia Syndrome Associated with Liposomal Daunorubicin." Pharmacotherapy 20 (2000): 1221-23.

Markman, M., A. Kennedy, K. Webster, G. Peterson, B. Kulp, and J. Belinson. "Phase 2 trial of liposomal doxorubicin (40 mg/m (2)) in Platinum/Paclitaxel-refractory ovarian and fallopian tube cancers and primary carcinoma of the peritoneum." Gynecologic Oncology 78 (September 2000): 369-72.


Abushullaih, Samer, Everardo Saad, and Paulo M. Hoff. "Characterizing hand-foot syndrome (HFS) caused by capecitabine." ASCO OnLine. 2000. 4 July 2001. <>.

"Clinical aspects of Xeloda." Roche Laboratories. 2000. 4 July 2001. <>.

Hoff, P. M., V. Valero, N. Ibrahim, J. Willey, and G. N. Hortobagyi. "Prolonged infusion of vinorelbine causing hand-foot syndrome." ASCO OnLine. 1997. 4 July 2001. <>.

"Prevention and management of Doxil-related side effects: Basic strategies." ASCO OnLine. 1998. 5 July 2001. <>.

Titgan, M. A. "Prevention of palmar-plantar erythrodysesthesia associated with liposomal-encapsulated doxorubicin by oral dexamethasone." ASCO OnLine. 1997. 5 July 2001. <>.

Vail, D. M., R. Chun, D. H. Thamm, L. D. Garrett, A. J. Cooley, and J. E. Obradovich. "Efficacy of pyridoxine to ameliorate the cutaneous toxicity associated with Doxil: A randomized, double-blind clinical trial using a canine model." ASCO OnLine. 1998. 5 July 2001. <>.

Paul A. Johnson, Ed.M.


Dose-limited drug

A drug for which the proper dosage is determined by the reaction of each individual patient to the drug.

Cite this article
Pick a style below, and copy the text for your bibliography.

  • MLA
  • Chicago
  • APA

"Hand-Foot Syndrome." Gale Encyclopedia of Cancer. . 24 Mar. 2019 <>.

"Hand-Foot Syndrome." Gale Encyclopedia of Cancer. . (March 24, 2019).

"Hand-Foot Syndrome." Gale Encyclopedia of Cancer. . Retrieved March 24, 2019 from

Learn more about citation styles

Citation styles gives you the ability to cite reference entries and articles according to common styles from the Modern Language Association (MLA), The Chicago Manual of Style, and the American Psychological Association (APA).

Within the “Cite this article” tool, pick a style to see how all available information looks when formatted according to that style. Then, copy and paste the text into your bibliography or works cited list.

Because each style has its own formatting nuances that evolve over time and not all information is available for every reference entry or article, cannot guarantee each citation it generates. Therefore, it’s best to use citations as a starting point before checking the style against your school or publication’s requirements and the most-recent information available at these sites:

Modern Language Association

The Chicago Manual of Style

American Psychological Association

  • Most online reference entries and articles do not have page numbers. Therefore, that information is unavailable for most content. However, the date of retrieval is often important. Refer to each style’s convention regarding the best way to format page numbers and retrieval dates.
  • In addition to the MLA, Chicago, and APA styles, your school, university, publication, or institution may have its own requirements for citations. Therefore, be sure to refer to those guidelines when editing your bibliography or works cited list.